ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,543Medicare Part D Prescriptions Filled, Including Refills

Rank: 355 out of 5176

$864K Total Retail Price of All Prescriptions

Rank: 380 out of 5176

571 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 571 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 10,243 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 547 427 1 1
AMLODIPINE BESYLATE 517 437 2 2
METFORMIN HCL 465 323 3 7
METOPROLOL TARTRATE 384 335 4 6
CRESTOR 361 317 5 15
LOSARTAN POTASSIUM 336 280 6 14
OMEPRAZOLE 327 237 7 3
PLAVIX 318 281 8 29
NEXIUM 298 242 9 16
RAMIPRIL 292 254 10 50
ZOLPIDEM TARTRATE 265 226 11 17
ENALAPRIL MALEATE 262 173 12 22
LOVAZA 249 199 13 43
CLOPIDOGREL 227 187 14 26
ADVAIR DISKUS 226 187 15 32
CARVEDILOL 221 199 16 24
LISINOPRIL 218 146 17 5
MELOXICAM 206 171 18 53
DIOVAN 178 145 19 19
ALENDRONATE SODIUM 175 171 20 18
GLIMEPIRIDE 174 131 21 37
LOSARTAN-HYDROCHLOROTHIAZIDE 169 130 22 35
JANUVIA 169 136 22 25
LEVOTHYROXINE SODIUM 152 152 24 4
ATENOLOL 147 118 25 12
TRAMADOL HCL 140 97 26 40
PROAIR HFA 135 114 27 60
DIOVAN HCT 134 120 28 39
ATORVASTATIN CALCIUM 131 103 29 9
FUROSEMIDE 128 119 30 8
TAMSULOSIN HCL 98 98 31 20
JANUMET 95 57 32 77
FLUTICASONE PROPIONATE 94 85 33 38
METOPROLOL SUCCINATE 91 71 34 11
LANTUS SOLOSTAR 87 42 35 70
HYDROCHLOROTHIAZIDE 87 68 35 10
SINGULAIR 81 64 37 62
LIDODERM 80 80 38 59
ALCOHOL SWABS 78 64 39 115
AMLODIPINE BESYLATE-BENAZEPRIL 77 73 40 55
WARFARIN SODIUM 75 65 41 13
CLONIDINE HCL 74 74 42 79
MECLIZINE HCL 66 60 43 81
INDAPAMIDE 64 64 44 257
GABAPENTIN 64 51 44 21
LIPITOR 63 54 46 51
VOLTAREN 57 41 47 97
ALLOPURINOL 57 53 47 41
PRAVASTATIN SODIUM 56 34 49 23
AZITHROMYCIN 55 40 50 42
PRANDIN 54 48 51 150
NITROGLYCERIN PATCH 54 53 51 149
BENICAR 51 51 53 100
BONIVA 50 47 54 236
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.